Dobutamine Dosing Chart
Start dobutamine at 2.5 μg/kg/min and titrate upward every 5-15 minutes based on hemodynamic response, with a usual effective range of 2-20 μg/kg/min and rarely exceeding 20 μg/kg/min in acute heart failure. 1, 2
Starting Dose
- Initial infusion rate: 2-2.5 μg/kg/min without a loading bolus 1, 3
- Alternative conservative start: 0.5-1.0 μg/kg/min for very unstable patients 2
Titration Protocol
Increase the dose every 5-15 minutes based on clinical response 1, 4:
- Monitor systolic blood pressure, urine output, heart rate, and signs of end-organ perfusion
- Double the dose every 15 minutes according to response or tolerability 1
- Titration increments can be in 2.5 μg/kg/min steps 4
Usual Effective Dose Range
- 2-20 μg/kg/min is the typical therapeutic range 1, 3, 2
- Most patients respond adequately within this range
Maximum Dose
- Doses >20 μg/kg/min are rarely needed 1
- In patients on beta-blockers, doses may need to increase to 20 μg/kg/min to overcome beta-blockade 3
- On rare occasions, up to 40 μg/kg/min has been required 2
Dose-Limiting Factors
Titration is typically limited by 1:
- Excessive tachycardia (heart rate >100-120 bpm)
- Arrhythmias (ventricular or atrial)
- Myocardial ischemia
- Hypotension (though dobutamine can have mild vasodilator effects)
Context-Specific Dosing
Acute Decompensated Heart Failure with SBP <85 mmHg
- Start at 2.5 μg/kg/min, double every 15 minutes 1
- Target: adequate urine output (>100 mL/h), improved perfusion, reduced dyspnea
Cardiogenic Shock
- Initial: 2.5 μg/kg/min 4
- Increase gradually at 5-10 minute intervals up to 10 μg/kg/min or until hemodynamic improvement 4
- May combine with vasopressor (norepinephrine preferred over dopamine) if persistent hypotension 5
Patients on Beta-Blockers
- Higher doses (up to 20 μg/kg/min) may be required to restore inotropic effect 3
- Consider that dobutamine's effects occur distal to beta-receptors is NOT true—this applies to milrinone, not dobutamine
Weaning Protocol
- Gradual tapering is essential 3
- Decrease by 2 μg/kg/min steps 3
- Simultaneously optimize oral therapy during weaning
- Rapid cessation can lead to hemodynamic decompensation
Monitoring Requirements
Continuous monitoring mandatory 3:
- ECG telemetry (arrhythmia detection)
- Blood pressure (invasive arterial line preferred in shock) 5
- Urine output (bladder catheter)
- Clinical signs of perfusion (skin temperature, mental status)
- When possible: cardiac output, central venous pressure, pulmonary capillary wedge pressure 1, 4
Critical Caveats
- No loading bolus is used with dobutamine 3, 2
- Dobutamine may facilitate AV nodal conduction in atrial fibrillation, causing rapid ventricular rates 3
- In patients with coronary artery disease, monitor closely for ischemia as dobutamine increases myocardial oxygen demand
- Elimination is rapid after cessation (half-life 2-3 minutes) 3
- Do not mix with sodium bicarbonate or other alkaline solutions 2
- Diluted solutions should be used within 24 hours 2